Pharmacological intervention in renal fibrosis and vascular sclerosis

Journal of Nephrology

Volumn 14, Issue 5, 2001, Pages 332-339

  Becker, G J ^a   Perkovic, V ^a   Hewitson, T D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Glomerulosclerosis; Interstitial fibrosis; Vascular sclerosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; DECORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HALOFUGINONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PIRFENIDONE; PLATELET DERIVED GROWTH FACTOR; PRAVASTATIN; SIMVASTATIN; THEOPHYLLINE;

ARTERIOSCLEROSIS; DISEASE ASSOCIATION; DISEASE COURSE; FIBROBLAST; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; KIDNEY BLOOD VESSEL; KIDNEY FAILURE; KIDNEY FIBROSIS; MESANGIUM CELL; MORTALITY; REVIEW; VASCULAR SMOOTH MUSCLE;

COLLAGEN; FIBROSIS; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MUSCLE, SMOOTH, VASCULAR; PENTOXIFYLLINE; PRAVASTATIN;

EID: 0035180324     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
2. Pathways to renal fibrosis
3. Growth factor pathways in proliferative glomerulonephritis
4. The hyperfiltration theory: A paradigm shift in nephrology
5. The role of physical forces in alterations of mesangial cell function
6. Renal injury from angiotensin II-mediated hypertension
7. Effects and interactions of endothelial-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth
8. Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney
9. Cytokines and glomerulosclerosis
10. The activated mesangial cell: A glomerular "myofibroblast"?
11. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis
12. Renal collagen synthesis and its control
13. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation
14. Enhanced expression of "muscle-specific" actin in glomerulonephritis
15. Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease
16. Mechanisms of progressive renal disease in glomerulonephritis
17. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis
18. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease
19. Paracrine stimulation of human renal fibroblasts by proximal tubule cells
20. Tubulointerstitial actions of endothelins in the kidney: Roles in health and disease
21. The role of tubulointerstitial injury in chronic renal failure
22. Interstitial myofibroblasts in experimental renal infection and scarring
23. Human renal cortical interstitial cells with some features of smooth muscle cell participate in tubulointerstitial and crescentic glomerular injury
24. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
25. Interstitial myofibroblasts in IgA glomerulonephritis
26. 1 (III) collagen expression in experimental tubulointerstitial nephritis
27. High glucose stimulates proliferation and collagen I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGFbeta progression
28. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation
29. Accelerated atherosclerosis in prolonged maintenance hemodialysis
30. Culture of vascular smooth muscle cells from arteries of the rat kidney
31. Proliferation of smooth muscle cells in the inner and outer layers of the tunica media of arteries: An in vitro study
32. A review of the proliferative behaviour, morphology and phenotypes of vascular smooth muscle
33. Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy
34. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density
35. Signaling events mediating the additive effects of olsic acid and angiotensin II on vascular smooth muscle migration
36. Collagen synthesis of human arterial smooth muscle cells: Effects of platelet-derived growth factor, transforming growth factor-beta 1 and interleukin-1
37. Cell biology of atherosclerosis
38. Prevention of progression of renal fibrosis: How far are we?
39. Role of dietary protein and blood pressure in the progression of renal disease
40. Dietary protein intake and the progressive nature of kidney diseases: The role of haemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in ageing, renal ablation and intrinsic renal disease
41. The effect of protein restriction on the progression of renal insufficiency
42. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
43. Cellular mechanisms of lipid injury in the glomerulus
44. Chemokine blockade as a therapy for renal disease
45. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease
46. Fully human anti-interleukin-8 monoclonal antibodies: Potential therapeutics for treatment of inflammatory disease states
47. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment
48. Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization
49. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts
50. Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells - Association with CREB transcription factor activation
51. Angiotensin II induces hypertrophy and hyperplasia in adult human mesangial cells
52. Angiotensin II type-2 receptors stimulate collagen synthesis in cultures vascular smooth muscle cells
53. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure
54. Use of perindopril in the prevention of renal interstitial expansion in Type 2 diabetic patients
55. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle migration and proliferation after ballon catheter injury
56. Endothelins, vasoactive mediators of renal function in health and disease
57. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries
58. Role of endothelin as a mitogen in experimental glomerulonephritis in rats
59. Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists
60. Simultaneous blockade of endothelin A and B receptors in ischaemic acute renal failure is detrimental to long term kidney function
61. Suppression of experimental glomerulonephritis by anti-serum against transforming growth factor β1
62. Antibodies against transmorning growth factor -beta1 suppresses intimal hyperplasia in a rat model
63. Pirfenidone prevents collagen accumulation in the remnant kidney in rats with partial nephrectomy
64. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
65. Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
66. Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
67. Connective tissue growth factor: A potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease
68. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis
69. PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction
70. Antiatherothrombotic properties of statins
71. Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation
72. Vasodilator agents modulate rat glomerular mesangial cell growth and collagen synthesis
73. In vitro effects of simvastatin on tubulointerstitial cells in a human model of cyclosporin nephrotoxicity
74. Evidence of a role of Ki-RAS in the stimulated proliferation of renal fibroblasts
75. Renal tubulointerstitial fibrosis: New thoughts on its development and progression
76. Pentoxifylline reduces in vitro renal myofibroblast proliferation and collagen secretion
77. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
78. Dipyridamole inhibits human mesangial cell proliferation
79. Dipyridamole inhibits PDGF- and bFGF-induced vascular smooth muscle cell proliferation
80. Dipyridamole inhibits in vitro renal myofibroblast proliferation and collagen synthesis
81. Role of heparin as a protective agent following reduction in renal mass
82. Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vivo studies
83. Heparin and glomerular epithelial cell-secreted heparin like species inhibit mesangial cell proliferation
84. Effect on heparin derived fractions on the proliferation and protein synthesis of cells in culture
85. Inhibition of glomerular mesangial cell proliferation and extracellular matrix deposition by halofuginone
86. Inhibition of collagen synthesis, smooth muscle cell proliferation and injury induced hyperplasia by halofuginone
87. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement
88. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
89. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
90. Therapeutic approaches to organ fibrosis
91. Relaxin: A pleiotropic hormone
92. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease
93. Relaxin induces an extracellular matrix degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo
94. Pirfenidone prevents the progression of irreversible glomerular sclerotic lesions in rats
95. Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
96. Chronic progressive interstitial fibrosis in renal disease - Are there novel pharmacological approaches?